⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Diamond Pharma and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Diamond Pharma
↗Damascus, Syria
Diamond Pharma is a Syrian-based pharmaceutical manufacturing company established in 2003. The company specializes in the production and distribution of a wide range of branded generic pharmaceutical products, including tablets, capsules, sterile dosage forms, and semi-solids, across various therapeutic categories such as cardiovascular, respiratory, and anti-diabetic medicines.
Operating out of a 17,000 m² facility in Damascus, the company emphasizes adherence to international Good Manufacturing Practices (GMP) and holds multiple ISO certifications (9001, 14001, 45001). They maintain a significant product portfolio of over 110 medicines and focus on providing affordable, high-quality healthcare solutions to regional and international markets.
CLASSIFICATION
SIZE & FINANCIALS
Employees:501-1000
Founded:2003
Ownership:private
Status:operating
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Small molecule
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
COMPETITION
Position:Niche Player
LEADERSHIP
Key Executives:
Ahmad Emad Al Ashkar - Manager
LINKS
Website:diamondpharma.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Diamond Pharma. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.